ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,614,000 | -14.6% | 65,000 | -35.0% | 0.27% | -43.5% |
| Q1 2020 | $11,261,000 | -19.1% | 100,000 | 0.0% | 0.48% | -11.4% |
| Q4 2019 | $13,912,000 | -3.7% | 100,000 | -33.3% | 0.54% | -7.3% |
| Q3 2019 | $14,448,000 | -16.4% | 150,000 | 0.0% | 0.58% | -17.2% |
| Q2 2019 | $17,273,000 | +17.4% | 150,000 | +20.0% | 0.70% | +16.3% |
| Q1 2019 | $14,713,000 | – | 125,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |